{"id":{"repo_id":"mit","oai_identifier":"oai:dspace.mit.edu:1721.1/155617"},"canonical_url":"https://search.dev.ndltd.org/etd/mit/oai:dspace.mit.edu:1721.1/155617","repository":{"repo_id":"mit","name":"MIT","base_url":"https://dspace.mit.edu/oai/request"},"display":{"title":"Overcoming Challenges in Cellular Therapies: A Systems Engineering Approach for Equitable Access","abstract":"Cellular and gene therapies have ushered in a new era of medical treatment, promising cures previously thought unattainable. Technologies like CRISPR/Cas9 enable precise genome manipulation, yet challenges persist in therapy delivery, prompting the rise of ex vivo approaches. Despite the promise of adaptive cell therapies, high development costs, manufacturing complexities, and regulatory hurdles hinder widespread adoption. The lack of agreement in the field with respect to centralized versus decentralized manufacturing models and the choice between autologous and allogeneic cell sources pose additional challenges. Equally as critical for global access to these therapies, personnel shortages and specialized expertise requirements must be addressed. A systems engineering approach offers a framework for overcoming these barriers, facilitating comprehensive bioprocess design analysis. Ultimately, developing a descriptive model for analyzing therapeutic delivery is crucial for ensuring equitable access to these transformative therapies worldwide.","abstract_html":"Cellular and gene therapies have ushered in a new era of medical treatment, promising cures previously thought unattainable. Technologies like CRISPR/Cas9 enable precise genome manipulation, yet challenges persist in therapy delivery, prompting the rise of ex vivo approaches. Despite the promise of adaptive cell therapies, high development costs, manufacturing complexities, and regulatory hurdles hinder widespread adoption. The lack of agreement in the field with respect to centralized versus decentralized manufacturing models and the choice between autologous and allogeneic cell sources pose additional challenges. Equally as critical for global access to these therapies, personnel shortages and specialized expertise requirements must be addressed. A systems engineering approach offers a framework for overcoming these barriers, facilitating comprehensive bioprocess design analysis. Ultimately, developing a descriptive model for analyzing therapeutic delivery is crucial for ensuring equitable access to these transformative therapies worldwide.","abstract_has_math":false,"creators":["Latouche, Eduardo Luis"],"institution":"Massachusetts Institute of Technology","degree_name":"Master","degree_level":null,"degree_discipline":null,"degree_department":"System Design and Management Program.","school":null,"contributors":[],"advisors":["Rubin, Joan"],"committee_chairs":[],"committee_members":[],"year":2024,"date_issued":"2024-05","date_published":"2024-05","updated_at":"2026-07-22T22:22:08Z","subjects":[],"languages":[],"rights":["In Copyright - Educational Use Permitted","Copyright retained by author(s)"],"rights_urls":["https://rightsstatements.org/page/InC-EDU/1.0/"],"identifier_entries":[]},"links":{"outbound_url":"https://hdl.handle.net/1721.1/155617","outbound_label":"Handle","outbound_source":"dc:identifier.uri"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.advisor","label":"Advisor","values":["Rubin, Joan"]},{"key":"dc:contributor.department","label":"Department","values":["System Design and Management Program."]},{"key":"dc:creator","label":"Author","values":["Latouche, Eduardo Luis"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.accessioned","label":"Dc Date Accessioned","values":["2024-07-10T20:19:40Z"]},{"key":"dc:date.available","label":"Dc Date Available","values":["2024-07-10T20:19:40Z"]},{"key":"dc:date.issued","label":"Date","values":["2024-05"]},{"key":"dc:publisher","label":"Institution","values":["Massachusetts Institute of Technology"]},{"key":"dc:type","label":"Dc Type","values":["Thesis"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Master","Master of Science in Engineering and Management"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:rights","label":"Dc Rights","values":["In Copyright - Educational Use Permitted","Copyright retained by author(s)"]},{"key":"dc:rights.uri","label":"Rights URI","values":["https://rightsstatements.org/page/InC-EDU/1.0/"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["https://hdl.handle.net/1721.1/155617"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Cellular and gene therapies have ushered in a new era of medical treatment, promising cures previously thought unattainable. Technologies like CRISPR/Cas9 enable precise genome manipulation, yet challenges persist in therapy delivery, prompting the rise of ex vivo approaches. Despite the promise of adaptive cell therapies, high development costs, manufacturing complexities, and regulatory hurdles hinder widespread adoption. The lack of agreement in the field with respect to centralized versus decentralized manufacturing models and the choice between autologous and allogeneic cell sources pose additional challenges. Equally as critical for global access to these therapies, personnel shortages and specialized expertise requirements must be addressed. A systems engineering approach offers a framework for overcoming these barriers, facilitating comprehensive bioprocess design analysis. Ultimately, developing a descriptive model for analyzing therapeutic delivery is crucial for ensuring equitable access to these transformative therapies worldwide."]},{"key":"dc:description.degree","label":"Dc Description Degree","values":["S.M."]},{"key":"dc:title","label":"Title","values":["Overcoming Challenges in Cellular Therapies: A Systems Engineering Approach for Equitable Access"]}]}],"canonical_facts":{"dc:contributor.advisor":["Rubin, Joan"],"dc:contributor.department":["System Design and Management Program."],"dc:creator":["Latouche, Eduardo Luis"],"dc:date.accessioned":["2024-07-10T20:19:40Z"],"dc:date.available":["2024-07-10T20:19:40Z"],"dc:date.issued":["2024-05"],"dc:description.abstract":["Cellular and gene therapies have ushered in a new era of medical treatment, promising cures previously thought unattainable. Technologies like CRISPR/Cas9 enable precise genome manipulation, yet challenges persist in therapy delivery, prompting the rise of ex vivo approaches. Despite the promise of adaptive cell therapies, high development costs, manufacturing complexities, and regulatory hurdles hinder widespread adoption. The lack of agreement in the field with respect to centralized versus decentralized manufacturing models and the choice between autologous and allogeneic cell sources pose additional challenges. Equally as critical for global access to these therapies, personnel shortages and specialized expertise requirements must be addressed. A systems engineering approach offers a framework for overcoming these barriers, facilitating comprehensive bioprocess design analysis. Ultimately, developing a descriptive model for analyzing therapeutic delivery is crucial for ensuring equitable access to these transformative therapies worldwide."],"dc:description.degree":["S.M."],"dc:identifier.uri":["https://hdl.handle.net/1721.1/155617"],"dc:publisher":["Massachusetts Institute of Technology"],"dc:rights":["In Copyright - Educational Use Permitted","Copyright retained by author(s)"],"dc:rights.uri":["https://rightsstatements.org/page/InC-EDU/1.0/"],"dc:title":["Overcoming Challenges in Cellular Therapies: A Systems Engineering Approach for Equitable Access"],"dc:type":["Thesis"],"thesis:degree_name":["Master","Master of Science in Engineering and Management"]},"updated_at":"2026-07-22T22:22:08Z"}